en

PRODUCT DETAIL

REFERO 550 mg filmom obalené tablety

Code 4379A
MA number 15/0076/13-S
Product Form: tbl flm 98x550 mg (blis.PVC/PE/PVDC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/INTESTINAL ANTIINFECTIVES
A07A INTESTINAL ANTIINFECTIVES
A07AA Antibiotics
A07AA11 Rifaximin
Shelf life: 36
Container: blister PVC/PE/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 05.03.2013
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_REFERO 550 mg tbl flm_05.2021.pdf  
SPC: SPC_REFERO 550 mg tbl flm_09.2022.pdf  
Safety feature Yes
Data update: 30.04.2018
eu-flag.png sk-flag.png